Access across
the world.
Evidence-based testing for the detection and identification of infectious diseases.
Mayo Clinic’s internationally-renowned clinical microbiology laboratories span all areas of conventional and molecular medical microbiology, offering a broad selection of tests designed for rapid identification and in depth characterization of the causative agents of infectious diseases.
Our laboratories have developed and implemented culture techniques; immunoassays; antimicrobial susceptibility testing; and molecular methods for rapid detection, identification, and characterization; and provision treatment guidance for microbial pathogens.
Results That Matter
We're dedicated to our patients' health and well-being,
and proud of the outstanding outcomes we achieve.
3 million
tests performed annually
70
years of diagnosing and treating infectious diseases.
7
specialized laboratories performing
infectious disease testing
24/7
support from Mayo Clinic physicians and scientists
Physician-lead subspecialized laboratories
Our laboratories are managed by physicians and scientists with expert knowledge regarding the clinical implications of each test result and how it can impact patient care.
The right tests, not the most tests
Our clinicians and laboratorians focus on maintaining high-quality, cost-effective, and
efficient care by using algorithmic, evidence-based approaches that lead to correct diagnoses and treatment, while minimizing unnecessary testing
Access across
the globe
Every laboratory offers testing; but, at Mayo Clinic Laboratories, we offer a service that allow patients access to Mayo Clinic experts from across the world in addition to our comprehensive testing menu.
COVID-19 Resource Center
We are rapidly expanding our COVID-19 testing to provide accurate information for health care professionals on the front lines of this crisis. We will continue coordinating closely with state and federal officials to offer testing in the areas with the greatest need.
The Latest
Cytomegalovirus, or CMV, is a common cause of disease in the transplant population. In some patients who are diagnosed with CMV and are on antiviral treatment for infections, the virus may develop resistance to the drugs. This “Hot Topic” will provide an overview of a new test developed by Mayo Clinic Laboratories, which uses next-generation sequencing technology to identify mutations in the genome of CMV that may be associated with antiviral resistance.
Maria Alice Willrich, Ph.D., was featured in an article in "360Dx" discussing therapeutic monoclonal antibodies (t-mAbs).
In this month’s “Hot Topic,” Robin Patel, M.D., will discuss the bacteria that cause pertussis, also known as whooping cough. Pertussis is highly contagious and spreads rapidly through families, schools, and hospitals. While adults and children may have relatively mild symptoms, the disease can be deadly for infants and newborns.
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss diagnostic testing options for patients with suspected neuroinvasive Lyme disease or Lyme neuroborreliosis.
